Press Release

Keensight Capital invests in Biovian, a leading biopharmaceutical contract development and manufacturing organization (CDmO)

By WeAreBlowMay 23, 2018February 1st, 2019No Comments

Download Télécharger

Previous PostTheodor Wuppermann joins Keensight Capital as Associate Director
Next PostPIXID continues European expansion with acquisition of Dutch staffing CRM supplier Carerix